FTF-17145-36090
1 vaccination
1 coded response
9 check-ins
0 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 641 / MO
- Registered
- 2022-12-05
- Relationship
- Child or adolescent in my care
- Guardian
- 4QK-14744-76725
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-12-05
Registered in v-safe
-
2022-12-05
Dose 1 — Pfizer-BioNTech
- 2022-12-05
- 2022-12-07
- 2022-12-09
- 2022-12-10
- 2022-12-12
- 2022-12-19
- 2022-12-26
- 2023-01-02
-
2023-03-06
Survey response — 3 months, dose 1, under 3MedDRA: Ear infection, Tympanic membrane perforation — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-06
Report sent to call center — 3 months, dose 1, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-12-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-06 | Unsuccessful |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ear infection | · | · | ✓ |
| SD | Tympanic membrane perforation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release